StoneWise Selected into Frost & Sullivan's AI4LS Blue Paper, Technological Strength Recognized by Industry Authority!
Recently, the company was invited to participate in the compilation of the industry blue book by Frost & Sullivan, a world-renowned growth consulting firm. This signifies that the company's technical accumulation and industry insights in the field of AI-driven innovative drug R&D have been highly recognized by international authoritative institutions.
The blue book will showcase our technological breakthroughs in multiple projects as an industry benchmark case — such as the practical experience of rapidly discovering privileged scaffolds through the AI platform, helping partners shorten R&D cycles and improve druggability success rates. It aims to provide actionable technical pathways and commercialization references for the industry.
Recommended Reading
Scan the QR code below to access the report
